ASHLEY BURRISS: Open Payments
NPI 1558892901 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,558 in 52 payments from 28 companies in 2025. Trend: 2023 $828 · 2024 $784 · 2025 $6,558
Travel & lodging: $3,064Consulting: $2,258Food & beverage: $1,137Education: $101
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $4,827 |
| Genmab U.S., Inc. | 1 | $683 |
| Astellas Pharma US Inc | 8 | $208 |
| Syndax Pharmaceuticals, Inc. | 2 | $187 |
| Incyte Corporation | 1 | $96 |
| Daiichi Sankyo Inc. | 4 | $83 |
| Merck Sharp & Dohme LLC | 2 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| TerSera Therapeutics LLC | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
Products named: Epkinly, Niktimvo, Enhertu, Xtandi, IMBRUVICA, KEYTRUDA, Padcev, VENCLEXTA.
Industry payments across SC — which companies pay providers there.
